Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
JDMF
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 1,1'-hbcb
2. Avagard
3. Chlorhexamed
4. Chlorhexidine Bigluconate
5. Chlorhexidine Digluconate
6. Chlorhexidine Gluconate
7. Corsodyl Ici
8. Curasept Ads 220
9. Dyna-hex
10. Eludril
11. Gibitan
12. Hexidine
13. Hibiclens
14. Hibident
15. Hibiscrub
16. Hibisol
17. Hibitane
18. Peridex
19. Perio Chip
1. Chlorhexidine Gluconate
2. 1308292-96-7
3. Cid 9939931
4. Chembl1628
5. Schembl34467
6. Amy32023
7. (1e)-2-[6-[[amino-[(e)-[amino-(4-chloroanilino)methylidene]amino]methylidene]amino]hexyl]-1-[amino-(4-chloroanilino)methylidene]guanidine;(2r,3s,4r,5r)-2,3,4,5,6-pentahydroxyhexanoic Acid
Molecular Weight | 701.6 g/mol |
---|---|
Molecular Formula | C28H42Cl2N10O7 |
Hydrogen Bond Donor Count | 12 |
Hydrogen Bond Acceptor Count | 9 |
Rotatable Bond Count | 18 |
Exact Mass | 700.2614991 g/mol |
Monoisotopic Mass | 700.2614991 g/mol |
Topological Polar Surface Area | 316 Ų |
Heavy Atom Count | 47 |
Formal Charge | 0 |
Complexity | 819 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 4 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 2 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
1 of 3 | |
---|---|
Drug Name | PAROEX |
Active Ingredient | CHLORHEXIDINE GLUCONATE |
Company | SUNSTAR AMERICAS (Application Number: A076434) |
2 of 3 | |
---|---|
Drug Name | PERIDEX |
Active Ingredient | CHLORHEXIDINE GLUCONATE |
Company | 3M (Application Number: N019028) |
3 of 3 | |
---|---|
Drug Name | PERIOCHIP |
Active Ingredient | CHLORHEXIDINE GLUCONATE |
Company | DEXCEL PHARMA (Application Number: N020774) |
Anti-Infective Agents, Local
Substances used on humans and other animals that destroy harmful microorganisms or inhibit their activity. They are distinguished from DISINFECTANTS, which are used on inanimate objects. (See all compounds classified as Anti-Infective Agents, Local.)
Dermatologic Agents
Drugs used to treat or prevent skin disorders or for the routine care of skin. (See all compounds classified as Dermatologic Agents.)
ABOUT THIS PAGE
A Chlohexidine Gluconate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Chlohexidine Gluconate, including repackagers and relabelers. The FDA regulates Chlohexidine Gluconate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Chlohexidine Gluconate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Chlohexidine Gluconate supplier is an individual or a company that provides Chlohexidine Gluconate active pharmaceutical ingredient (API) or Chlohexidine Gluconate finished formulations upon request. The Chlohexidine Gluconate suppliers may include Chlohexidine Gluconate API manufacturers, exporters, distributors and traders.
click here to find a list of Chlohexidine Gluconate suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Chlohexidine Gluconate written confirmation (Chlohexidine Gluconate WC) is an official document issued by a regulatory agency to a Chlohexidine Gluconate manufacturer, verifying that the manufacturing facility of a Chlohexidine Gluconate active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Chlohexidine Gluconate APIs or Chlohexidine Gluconate finished pharmaceutical products to another nation, regulatory agencies frequently require a Chlohexidine Gluconate WC (written confirmation) as part of the regulatory process.
click here to find a list of Chlohexidine Gluconate suppliers with Written Confirmation (WC) on PharmaCompass.
Chlohexidine Gluconate Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Chlohexidine Gluconate GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Chlohexidine Gluconate GMP manufacturer or Chlohexidine Gluconate GMP API supplier for your needs.
A Chlohexidine Gluconate CoA (Certificate of Analysis) is a formal document that attests to Chlohexidine Gluconate's compliance with Chlohexidine Gluconate specifications and serves as a tool for batch-level quality control.
Chlohexidine Gluconate CoA mostly includes findings from lab analyses of a specific batch. For each Chlohexidine Gluconate CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Chlohexidine Gluconate may be tested according to a variety of international standards, such as European Pharmacopoeia (Chlohexidine Gluconate EP), Chlohexidine Gluconate JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Chlohexidine Gluconate USP).
LOOKING FOR A SUPPLIER?